Logo image of XX.CA

AVANTE CORP (XX.CA) Stock Fundamental Analysis

TSX-V:XX - CA05352F1099 - Common Stock

0.84 CAD
0 (0%)
Last: 8/29/2025, 7:00:00 PM
Fundamental Rating

2

Taking everything into account, XX scores 2 out of 10 in our fundamental rating. XX was compared to 3 industry peers in the Diversified Consumer Services industry. The financial health of XX is average, but there are quite some concerns on its profitability. XX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

XX had negative earnings in the past year.
XX had a positive operating cash flow in the past year.
In the past 5 years XX reported 4 times negative net income.
In multiple years XX reported negative operating cash flow during the last 5 years.
XX.CA Yearly Net Income VS EBIT VS OCF VS FCFXX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M -4M

1.2 Ratios

XX's Return On Assets of -8.79% is fine compared to the rest of the industry. XX outperforms 66.67% of its industry peers.
XX's Return On Equity of -16.14% is fine compared to the rest of the industry. XX outperforms 66.67% of its industry peers.
Industry RankSector Rank
ROA -8.79%
ROE -16.14%
ROIC N/A
ROA(3y)-6.04%
ROA(5y)-6.99%
ROE(3y)-10.77%
ROE(5y)-16.93%
ROIC(3y)N/A
ROIC(5y)N/A
XX.CA Yearly ROA, ROE, ROICXX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10 -20

1.3 Margins

With a Gross Margin value of 39.27%, XX is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
XX's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for XX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.15%
GM growth 5Y10.86%
XX.CA Yearly Profit, Operating, Gross MarginsXX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

More info and screens

4

2. Health

2.1 Basic Checks

XX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, XX has about the same amount of shares outstanding.
Compared to 5 years ago, XX has more shares outstanding
The debt/assets ratio for XX is higher compared to a year ago.
XX.CA Yearly Shares OutstandingXX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
XX.CA Yearly Total Debt VS Total AssetsXX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of 1.78, we must say that XX is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.78, XX is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
A Debt/Equity ratio of 0.05 indicates that XX is not too dependend on debt financing.
The Debt to Equity ratio of XX (0.05) is better than 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 1.78
ROIC/WACCN/A
WACC7.93%
XX.CA Yearly LT Debt VS Equity VS FCFXX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M 10M 15M

2.3 Liquidity

XX has a Current Ratio of 1.84. This is a normal value and indicates that XX is financially healthy and should not expect problems in meeting its short term obligations.
XX's Current ratio of 1.84 is amongst the best of the industry. XX outperforms 100.00% of its industry peers.
XX has a Quick Ratio of 1.70. This is a normal value and indicates that XX is financially healthy and should not expect problems in meeting its short term obligations.
XX's Quick ratio of 1.70 is amongst the best of the industry. XX outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.84
Quick Ratio 1.7
XX.CA Yearly Current Assets VS Current LiabilitesXX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

More info and screens

1

3. Growth

3.1 Past

XX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 33.22%, which is quite impressive.
The Revenue has grown by 35.32% in the past year. This is a very strong growth!
XX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -7.50% yearly.
EPS 1Y (TTM)33.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%69.03%
Revenue 1Y (TTM)35.32%
Revenue growth 3Y22.97%
Revenue growth 5Y-7.5%
Sales Q2Q%28.75%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
XX.CA Yearly Revenue VS EstimatesXX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
XX.CA Yearly EPS VS EstimatesXX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 0 0.05 -0.05 0.1 -0.1 -0.15

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

XX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XX.CA Price Earnings VS Forward Price EarningsXX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

XX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. XX is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.22
XX.CA Per share dataXX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for XX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AVANTE CORP

TSX-V:XX (8/29/2025, 7:00:00 PM)

0.84

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)08-11 2025-08-11
Earnings (Next)11-24 2025-11-24
Inst Owners0.12%
Inst Owner ChangeN/A
Ins Owners22.55%
Ins Owner ChangeN/A
Market Cap22.39M
Analysts82.86
Price Target2.3 (173.81%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.66
P/FCF N/A
P/OCF 66.62
P/B 1.78
P/tB 3.8
EV/EBITDA 16.22
EPS(TTM)-0.08
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0.01
OCFY1.5%
SpS1.27
BVpS0.47
TBVpS0.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.79%
ROE -16.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.27%
FCFM N/A
ROA(3y)-6.04%
ROA(5y)-6.99%
ROE(3y)-10.77%
ROE(5y)-16.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.15%
GM growth 5Y10.86%
F-Score5
Asset Turnover1.46
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA 0.5
Cap/Depr 21.03%
Cap/Sales 1.04%
Interest Coverage N/A
Cash Conversion 28.65%
Profit Quality N/A
Current Ratio 1.84
Quick Ratio 1.7
Altman-Z 1.78
F-Score5
WACC7.93%
ROIC/WACCN/A
Cap/Depr(3y)43.23%
Cap/Depr(5y)32.2%
Cap/Sales(3y)2.35%
Cap/Sales(5y)1.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%69.03%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)35.32%
Revenue growth 3Y22.97%
Revenue growth 5Y-7.5%
Sales Q2Q%28.75%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y77.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y98.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y144%
OCF growth 3Y-43.11%
OCF growth 5YN/A